← Back to headlines
BTIG Adjusts Humacyte (HUMA) Price Target While Maintaining Bullish Outlook
BTIG has lowered its price target for Humacyte (HUMA) but continues to hold a bullish view on the company's long-term opportunities.
29 Mar, 20:44 — 29 Mar, 20:44
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Illegal cigarette manufacturing: 9 Chinese, 4 locals arrested in Negros
just now
Boracay Water's Nabaoy Watershed Rehabilitation Validated by DENR
just now
Hybe Founder Bang Si-hyuk Faces Possible Arrest Over Alleged Stock Fraud
5m ago